知镜 Cognispect · 医学文献与研究工作台

Gastroesophageal reflux disease in chronic obstructive pulmonary disease and asthma: Results from the China Pulmonary Health study.

Huang K, Peng Y, Tang X, Li B, Yang T, Wang C.
Chinese medical journal · 2026-11-16 · PMID 43036897

文献摘要

Background Gastroesophageal reflux disease (GERD) is a common comorbidity of chronic obstructive pulmonary disease (COPD) and asthma. However, limited information is available on GERD among community-sourced patients with COPD and asthma in China. This study aimed to assess the prevalence of GERD and its association with respiratory symptoms and airway reversibility in these patients from the general population. Methods The China Pulmonary Health (CPH) study, a national cross-sectional survey, enrolled 57,779 adults aged ≥20 years from June 2012 to May 2015. Participants completed standard questionnaires and underwent pulmonary function tests. GERD was defined using the Gastroesophageal Reflux Disease Questionnaire (GerdQ). Airway reversibility was assessed via post-bronchodilator pulmonary function changes. Multivariate regressions examined the association of GERD with respiratory symptoms and airway reversibility. Results In total, 47,226 participants were included in the final analysis. The prevalence of GERD was 6.62% (95% confidence interval [CI]: 5.89-7.34%) in patients with COPD, and 13.73% (95% CI: 12.19-15.27%) and 12.38% (95% CI: 9.84-14.93%) in patients with asthma and asthma with airflow limitation, respectively. GERD was associated with nasal symptoms, cough, sputum, wheezing, and dyspnea in patients with COPD. GERD was also associated with nasal symptoms and dyspnea in patients with asthma. After adjusting for confounders, the asthma group with GERD had smaller postbronchodilator changes in forced expiratory volume in 1 s (FEV1) compared with those without GERD (B = -0.030, 95% CI: -0.055 to -0.005, P = 0.018), and the association remained after further adjusting for respiratory symptoms (B = -0.033, 95% CI: -0.058 to -0.008, P = 0.009). But postbronchodilator changes in FEV1 or forced vital capacity (FVC) did not differ between COPD patients with and without GERD. Conclusions GERD is prevalent and significantly associated with respiratory symptoms in patients with COPD and asthma. In patients with asthma, those with GERD had worse airway reversibility.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。